Skip to content
ESSA Pharma
  • Our Company
    • About Us
    • Executive Team
    • Board of Directors
    • Scientific Advisors
    • Careers
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Androgen Receptor
    • Aniten Compounds
    • Publications
  • News
  • Investors
    • Investor Info
    • Corporate Governance
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Investor Contact
    • Publications
    • SEC Regulatory Filings
  • Contact
ESSA PHARMA, INC. HAS BEGUN DEVELOPMENT OF A SECOND GENERATION ANITEN COMPOUND FOR THE TREATMENT OF HORMONE-DRIVEN CANCER

News

News Archives

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
Date Title
September 10, 2020

ESSA Pharma to Participate in Multiple Upcoming Investor Conferences

August 6, 2020

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020

July 31, 2020

ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000

July 28, 2020

ESSA Pharma Announces Proposed Public Offering of Common Shares

July 28, 2020

ESSA Pharma Announces Pricing of Public Offering of Common Shares

July 15, 2020

ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostrate Cancer

June 22, 2020

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II

May 27, 2020

ESSA Pharma to Present at Jefferies Virtual Healthcare Conference

May 15, 2020

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting

May 7, 2020

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020

  • «
  • 1
  • 2
  • 3
  • 4
  • …
  • 13
  • »
  • Home
  • Our Company
  • Executive Team
  • Board of Directors
  • Scientific Advisors
  • Careers
  • Pipeline
  • Expanded Access Policy
  • Androgen Receptor
  • Aniten Compounds
  • Publications
  • News
  • Press Releases
  • Investors
  • Corporate Governance
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Analyst Coverage
  • Investor Contact
  • Contact
  • Locations & Inquiries
© ESSA Pharma, Inc. 2020. All rights reserved. Privacy Policy | Terms & Conditions | Code of Conduct